About this policy
The comment period for the MolDX: Signatera and Minimal Residual Disease Testing for Colorectal Cancer DL38431 Local Coverage Determination (LCD) began on 09/26/19 and ended on 11/10/19. The notice period for MolDX: Minimal Residual Disease Testing for Colorectal Cancer L38431 begins on 09/03/20 and will become effective on 10/18/20. The title of the LCD was revised from MolDX: Signatera and Minimal Residual Disease Testing for Colorectal Cancer to MolDX: Minimal Residual Disease Testing for Colorectal Cancer. The comments below were received from the provider community.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.